Buscar en
Gastroenterología y Hepatología (English Edition)
Toda la web
Inicio Gastroenterología y Hepatología (English Edition) Renal aspergillosis after liver transplant: Report of an unusual case
Journal Information
Vol. 41. Issue 1.
Pages 30-31 (January 2018)
Vol. 41. Issue 1.
Pages 30-31 (January 2018)
Scientific letter
Full text access
Renal aspergillosis after liver transplant: Report of an unusual case
Aspergilosis renal posterior a trasplante hepático: informe de un caso infrecuente
Visits
987
Esteban Araos-Baeriswyla,b,
Corresponding author
earaos@med.puc.cl

Corresponding author.
, Catherina Moll-Manzurc
a Servicio de Medicina, Complejo Asistencial Dr. Sótero del Río, Santiago, Chile
b Departamento de Medicina Interna, Facultad de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile
c Facultad de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile
This item has received
Article information
Full Text
Bibliography
Download PDF
Statistics
Full Text

Invasive aspergillosis (IA) with a compromised urinary tract is extremely rare. We present the case of a patient who developed renal abscesses due to Aspergillus fumigatus following liver transplant (LT).

28-year-old man who had an LT 6 months ago due to autoimmune fulminant liver failure. User of tacrolimus (0.1mg/kg/day), prednisone 12.5mg/day and trimethoprim–sulfamethoxazole. He was admitted after experiencing dull lower back pain for two days, extending to the flank and right iliac fossa. He had no fever or vomiting. On admission, he was haemodynamically stable, afebrile and lucid. On the physical examination by anatomical region, the abdomen was sensitive to deep palpation and fist percussion of the flank and right iliac fossa. The patient presented with no palpable masses or signs of peritoneal irritation.

The lab tests showed preserved liver and kidney function. Urinalysis revealed leukocyturia (more than 50 white blood cells/mm3) with no bacteriuria. The CT scan of the abdomen and pelvis showed mild right-sided nephromegaly, with multiple irregular cystic lesions that spread into the pyelocalyceal system towards the third lower and middle segments. On the left side, a cystic lesion with slightly thickened walls was observed in the upper pole, measuring 2.5cm in diameter. The urine culture and bacilloscopies were negative. The chest CT scan revealed no pathological findings.

The kidney fluid collections were drained and significant amounts of purulent material were found. Neither bacteria nor microbacteria were investigated during the microbiological tests. The Kinyoun stain was negative. However, A. fumigatus was isolated in the culture.

Voriconazole was initiated with a loading dose, followed by 4mg/kg every 12h, with a good initial clinical response. One month later, the patient developed fever and abdominal pain. Urinalysis showed persistence of the aseptic leukocyturia. The control CT scan revealed significant progression of the right kidney fluid collections. It was decided to perform a right nephrectomy, which was carried out without incident. The immunosuppressive therapy was also changed to rapamycin (2mg/day) due to its antifungal effect. Voriconazole was discontinued after 9 months due to stabilisation of the left kidney lesion. To date, after 3 years of follow-up, the patient has suffered no relapses.

Invasive fungal infections (IFIs) are a significant cause of morbidity and mortality in post-transplant patients. In the case of those receiving liver transplants, the frequency ranges between 5.4% and 42%, with candidiasis being the most common aetiology, followed by Aspergillus spp.1

Between 1% and 10% of all cases of IFIs that occur in liver transplants are caused by Aspergillus spp.2,3 The vast majority relate to cases of pulmonary aspergillosis. Of these, approximately half present with systemic dissemination.1

Renal compromise due to Aspergillus spp is uncommon; however, it is possible that there may be a sub-diagnosis of this condition in patients with IA. A post-mortem study in patients with IA revealed that up to 12% had inflammatory kidney lesions that were not previously investigated.4

To date, only two cases of renal aspergillosis have been reported in liver transplant patients.5

The risk factors for developing IA in liver transplant patients include kidney failure, repeat transplant, fulminant liver failure as a reason for transplant, cytomegalovirus or herpes-6 viral infection, and severe immunosuppression.1,2

The aetiopathogenesis of renal compromise is not fully known. Nevertheless, several hypotheses have been proposed, including: haematogenous spread from another point; haematogenous seeding (in users of intravenous drugs); compromise of the upper urinary tract; and local seeding in cases of prior surgeries of the urinary tract.

Leukocyturia with a negative urine culture, although non-specific, is typical in lab tests.4

In liver transplant patients, the death rate due to IA ranges between 33% and 100%.2 Furthermore, the prognosis for renal compromise due to aspergillosis is poor. The majority of the cases reported in the literature show relapses and/or death despite treatment.4 Even where the few cases of renal compromise reported in the literature failed to reach definite conclusions regarding treatment, patients who underwent radical nephrectomy seemingly had better survival rates. Radical nephrectomy was performed in the two reported cases of renal aspergillosis in LT, showing good progress with no relapses after 1.5 and 7 years of follow-up.5

Although IA is an uncommon disease, a high degree of suspicion is required and an active search for fungal infectious agents, including Aspergillus spp, should be performed.

References
[1]
X. Liu, Z. Ling, L. Li, B. Ruan.
Invasive fungal infections in liver transplantation.
Int J Infect Dis, 15 (2011), pp. e298-e304
[2]
F. Barchiesi, S. Mazzocato, S. Mazzanti, R. Gesuita, E. Skrami, A. Fiorentini, et al.
Invasive aspergillosis in liver transplant recipients: epidemiology, clinical characteristics, treatment, and outcomes in 116 cases.
Liver Transpl, 21 (2015), pp. 204-212
[3]
J.E. Patterson.
Epidemiology of fungal infections in solid organ transplant patients.
Transpl Infect Dis, 1 (1999), pp. 229-236
[4]
A.W. Oosten, H.G. Sprenger, J.T.M. Van Leeuwen, N.E.L. Meessen, S. Van Assen.
Bilateral renal aspergillosis in a patient with AIDS: a case report and review of reported cases.
Aids Patient Care STDS, 22 (2008), pp. 1-6
[5]
X.C. Meng, T. Jiang, S.H. Yi, P.Y. Xie, Y.F. Guo, L. Quan, et al.
Renal aspergillosis after liver transplantation: clinical and imaging manifestations in two cases.
World J Gastroenterol, 20 (2014), pp. 18495-18502

Please cite this article as: Araos-Baeriswyl E, Moll-Manzur C. Aspergilosis renal posterior a trasplante hepático: informe de un caso infrecuente. Gastroenterol Hepatol. 2018;41:30–31.

Copyright © 2016. Elsevier España, S.L.U.. All rights reserved
Article options
Tools
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos